Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Parasitology and Mycology Rapid Tests and POC Pipeline Market Report Overview

Parasitology and mycology consist of rapid test kits. These are used for rapid diagnosis, with immediate results, through immunoassays for Plasmodium and Candida albicans. The Parasitology and Mycology Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials.

Key Territories ·        The US

·        Europe

·        Japan

·        China

·        Australia

Key Regulatory Paths ·        510(k)

·        CE

·        TGA

·        ICAC

·        NMPA

Leading Companies ·        All India Institute of Medical Sciences

·        Antigen Discovery Inc

·        Applied BioCode Inc

·        Aptus Biotech SL

·        Attogene Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Parasitology and Mycology Rapid Tests and POC Pipeline Market Segmentation by Territories

A few of the key territories for Parasitology and Mycology Rapid Tests and POC pipeline products are the US, Europe, Japan, China, and Australia among others. As of December 2023, the US accounted for the highest number of pipeline products.

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Territories, 2023 (%)

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Territories, 2023 (%)

Buy the Full Report for More Territory Insights into the Parasitology and Mycology Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Parasitology and Mycology Rapid Tests and POC Pipeline Market Segmentation by Regulatory Paths

A few of the key regulatory paths followed by the Parasitology and Mycology Rapid Tests and POC pipeline market are 510(k), CE, TGA, ICAC, and NMPA among others. As of December 2023, 510(k) was the most followed pathway for pipeline products in the market.

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy the Full Report for More Regulatory Path Insights into the Parasitology and Mycology Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Parasitology and Mycology Rapid Tests and POC Pipeline Market – Competitive Landscape

A few of the key companies associated with the Parasitology and Mycology Rapid Tests and POC Pipeline market are All India Institute of Medical Sciences, Antigen Discovery Inc., Applied BioCode Inc., Aptus Biotech SL, and Attogene Corp, among others.

All India Institute of Medical Sciences (AIIMS): AIIMS is headquartered in New Delhi, India. It provides medical education, biomedical research, and healthcare services. It also offers research services, teaching services, medical services, nursing services, and laboratory services among others. Furthermore, the institution provides DM (Doctorate of Medicine) and MCh (Master of Chirurgiae) super specialty courses in the areas of cardiology, oncology, cardiothoracic, and neurosurgery. AIIMS conducts research in the fields of neurosciences, genetics, and computer simulation of hormone-receptor interaction. It applies DNA recombinant technology, immunology, and electron microscopy to study diseases such as leprosy, malaria, tuberculosis, diabetes, diarrhea, hepatitis, fluorosis, and iodine deficiency.

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Companies, 2023

Parasitology and Mycology Rapid Tests and POC Pipeline Market Analysis by Companies, 2023

Buy the Full Report for More Company Insights into the Parasitology and Mycology Rapid Tests and POC Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Parasitology and Mycology Rapid Tests and POC Pipeline Market Territories Outlook

  • The US
  • Europe
  • Japan
  • China
  • Australia

Parasitology and Mycology Rapid Tests and POC Pipeline Market Regulatory Paths Outlook

  • 510(k)
  • CE
  • TGA
  • ICAC
  • NMPA

Scope

This report provides:

  • An extensive coverage of the Parasitology and Mycology Rapid Tests and POC under development.
  • An exhaustive list of major pipeline products and their details, including product descriptions, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of Parasitology and Mycology Rapid Tests and POC and lists all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Gather actionable insights from competitor information to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.
  • Identify and understand important and diverse types of Parasitology and Mycology Rapid Tests and POC under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abacus Diagnostica Ltd
Access Bio Inc
Acobiom
Adaltis Srl
All India Institute of Medical Sciences
Antigen Discovery Inc
Applied BioCode Inc
Aptus Biotech SL
Attogene Corp
Auburn University
Axxin
Beckman Coulter Inc
BioSynesis Inc
Biotechnology Assets SA
Biotype Innovation GmbH
Cascade Biosystems Inc
Cepheid Inc
Cerebro Biosystems
Ceres Nanosciences Inc
Ellume Ltd
EUROIMMUN US LLC
FK-Biotecnologia SA
Foundation for Innovative New Diagnostics
Fungea AB
G Medical Health and Wellness
Genetag Technology, Inc
Gennova Biopharmaceuticals Ltd
Genome Diagnostics Pvt Ltd
George Mason University
Great Basin Scientific Inc.
HealthTell Inc
Immunetics Inc
InBios International Inc
Institute for Development Research
Johns Hopkins University
L2 Diagnostics LLC
London School of Hygiene & Tropical Medicine
Luminex Corp
Mahidol Oxford Tropical Medicine Research Unit
Masaryk University
Massachusetts Institute of Technology
McGill University
Meridian Bioscience Inc
Microbiologics Inc
MiraVista Diagnostics LLC
MND Diagnostic LTD
MycoDART Inc
Mylab Discovery Solutions Pvt Ltd
Nagasaki University
Nanosphere Inc (Inactive)
NextGen Invitro Diagnostics Pvt Ltd
Novacyt SA
Ohio State University
OpGen Inc
OPKO Health Inc
Oregon Health & Science University
Ortho Clinical Diagnostics Holdings Plc
Pai Life Sciences Inc
Paramedical Srl
Peruvian Cayetano Heredia University
Phagolum Ltd.
PixCell Medical Technologies Ltd
Praxis Pharmaceutical SAU
Proplex Technologies Llc
Qiagen NV
RealSeq Biosciences Inc
Roche Diagnostics International Ltd
Seegene Inc
Serimmune Inc
Siemens Healthcare Diagnostics Inc
T2 Biosystems Inc
Taizhou ZECEN Biotech Co Ltd
Techinvention Lifecare Pvt Ltd
The Walter and Eliza Hall Institute of Medical Research
Transfusion & Transplantation Technologies (Inactive)
University of California
University of Colorado
University of Edinburgh
University of Georgia
University of Grenoble Alpes
University of Oxford
University of Tennessee
Virginia Commonwealth University
Washington University in St Louis
Washington University School of Medicine

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 7

|1.2 List of Figures 14

2 Introduction 15

2.1 Parasitology & Mycology Overview 15

3 Products under Development 16

3.1 Parasitology & Mycology – Pipeline Products by Stage of Development 16

3.2 Parasitology & Mycology – Pipeline Products by Territory 17

3.3 Parasitology & Mycology – Pipeline Products by Regulatory Path 18

3.4 Parasitology & Mycology – Pipeline Products by Estimated Approval Date 19

4 Parasitology & Mycology – Pipeline Products under Development by Companies 20

4.1 Parasitology & Mycology Companies – Pipeline Products by Stage of Development 20

4.2 Parasitology & Mycology – Pipeline Products by Stage of Development 24

5 Parasitology & Mycology Companies and Product Overview 27

5.1 Abacus Diagnostica Ltd Company Overview 27

5.1.1 Abacus Diagnostica Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

5.2 Access Bio Inc Company Overview 28

5.2.1 Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Acobiom Company Overview 29

5.3.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 Adaltis Srl Company Overview 30

5.4.1 Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 All India Institute of Medical Sciences Company Overview 36

5.5.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 36

5.6 Antigen Discovery Inc Company Overview 37

5.6.1 Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 37

5.7 Applied BioCode Inc Company Overview 38

5.7.1 Applied BioCode Inc Pipeline Products & Ongoing Clinical Trials Overview 38

5.8 Aptus Biotech SL Company Overview 39

5.8.1 Aptus Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 39

5.9 Attogene Corp Company Overview 40

5.9.1 Attogene Corp Pipeline Products & Ongoing Clinical Trials Overview 40

5.10 Auburn University Company Overview 41

5.10.1 Auburn University Pipeline Products & Ongoing Clinical Trials Overview 41

5.11 Axxin Company Overview 42

5.11.1 Axxin Pipeline Products & Ongoing Clinical Trials Overview 42

5.12 Beckman Coulter Inc Company Overview 43

5.12.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.13 BioSynesis Inc Company Overview 45

5.13.1 BioSynesis Inc Pipeline Products & Ongoing Clinical Trials Overview 45

5.14 Biotechnology Assets SA Company Overview 46

5.14.1 Biotechnology Assets SA Pipeline Products & Ongoing Clinical Trials Overview 46

5.15 Biotype Innovation GmbH Company Overview 47

5.15.1 Biotype Innovation GmbH Pipeline Products & Ongoing Clinical Trials Overview 47

5.16 Cascade Biosystems Inc Company Overview 48

5.16.1 Cascade Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

5.17 Cepheid Inc Company Overview 49

5.17.1 Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 49

5.18 Cerebro Biosystems Company Overview 50

5.18.1 Cerebro Biosystems Pipeline Products & Ongoing Clinical Trials Overview 50

5.19 Ceres Nanosciences Inc Company Overview 51

5.19.1 Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 51

5.20 Ellume Ltd Company Overview 52

5.20.1 Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

5.21 EUROIMMUN US LLC Company Overview 53

5.21.1 EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 53

5.22 FK-Biotecnologia SA Company Overview 55

5.22.1 FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 55

5.23 Foundation for Innovative New Diagnostics Company Overview 56

5.23.1 Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 56

5.24 Fungea AB Company Overview 58

5.24.1 Fungea AB Pipeline Products & Ongoing Clinical Trials Overview 58

5.25 G Medical Health and Wellness Company Overview 59

5.25.1 G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 59

5.26 Genetag Technology, Inc Company Overview 60

5.26.1 Genetag Technology, Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.27 Gennova Biopharmaceuticals Ltd Company Overview 61

5.27.1 Gennova Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

5.28 Genome Diagnostics Pvt Ltd Company Overview 62

5.28.1 Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

5.29 George Mason University Company Overview 65

5.29.1 George Mason University Pipeline Products & Ongoing Clinical Trials Overview 65

5.30 Great Basin Scientific Inc. Company Overview 66

5.30.1 Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 66

5.31 HealthTell Inc Company Overview 68

5.31.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 68

5.32 Immunetics Inc Company Overview 69

5.32.1 Immunetics Inc Pipeline Products & Ongoing Clinical Trials Overview 69

5.33 InBios International Inc Company Overview 70

5.33.1 InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 70

5.34 Institute for Development Research Company Overview 71

5.34.1 Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 71

5.35 Johns Hopkins University Company Overview 72

5.35.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 72

5.36 L2 Diagnostics LLC Company Overview 76

5.36.1 L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 76

5.37 London School of Hygiene & Tropical Medicine Company Overview 77

5.37.1 London School of Hygiene & Tropical Medicine Pipeline Products & Ongoing Clinical Trials Overview 77

5.38 Luminex Corp Company Overview 78

5.38.1 Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 78

5.39 Mahidol Oxford Tropical Medicine Research Unit Company Overview 79

5.39.1 Mahidol Oxford Tropical Medicine Research Unit Pipeline Products & Ongoing Clinical Trials Overview 79

5.40 Masaryk University Company Overview 80

5.40.1 Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 80

5.41 Massachusetts Institute of Technology Company Overview 81

5.41.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 81

5.42 McGill University Company Overview 82

5.42.1 McGill University Pipeline Products & Ongoing Clinical Trials Overview 82

5.43 Meridian Bioscience Inc Company Overview 84

5.43.1 Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 84

5.44 Microbiologics Inc Company Overview 85

5.44.1 Microbiologics Inc Pipeline Products & Ongoing Clinical Trials Overview 85

5.45 MiraVista Diagnostics LLC Company Overview 88

5.45.1 MiraVista Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 88

5.46 MND Diagnostic LTD Company Overview 89

5.46.1 MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview 89

5.47 MycoDART Inc Company Overview 90

5.47.1 MycoDART Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.48 Mylab Discovery Solutions Pvt Ltd Company Overview 91

5.48.1 Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

5.49 Nagasaki University Company Overview 92

5.49.1 Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 92

5.50 Nanosphere Inc (Inactive) Company Overview 93

5.50.1 Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

5.51 NextGen Invitro Diagnostics Pvt Ltd Company Overview 95

5.51.1 NextGen Invitro Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

5.52 Novacyt SA Company Overview 96

5.52.1 Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview 96

5.53 Ohio State University Company Overview 98

5.53.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 98

5.54 OpGen Inc Company Overview 99

5.54.1 OpGen Inc Pipeline Products & Ongoing Clinical Trials Overview 99

5.55 OPKO Health Inc Company Overview 100

5.55.1 OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.56 Oregon Health & Science University Company Overview 101

5.56.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 101

5.57 Ortho Clinical Diagnostics Holdings Plc Company Overview 102

5.57.1 Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 102

5.58 Pai Life Sciences Inc Company Overview 103

5.58.1 Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.59 Paramedical Srl Company Overview 104

5.59.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 104

5.60 Peruvian Cayetano Heredia University Company Overview 106

5.60.1 Peruvian Cayetano Heredia University Pipeline Products & Ongoing Clinical Trials Overview 106

5.61 Phagolum Ltd. Company Overview 107

5.61.1 Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 107

5.62 PixCell Medical Technologies Ltd Company Overview 108

5.62.1 PixCell Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

5.63 Praxis Pharmaceutical SAU Company Overview 109

5.63.1 Praxis Pharmaceutical SAU Pipeline Products & Ongoing Clinical Trials Overview 109

5.64 Proplex Technologies Llc Company Overview 110

5.64.1 Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 110

5.65 Qiagen NV Company Overview 111

5.65.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 111

5.66 RealSeq Biosciences Inc Company Overview 114

5.66.1 RealSeq Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 114

5.67 Roche Diagnostics International Ltd Company Overview 115

5.67.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

5.68 Seegene Inc Company Overview 119

5.68.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 119

5.69 Serimmune Inc Company Overview 120

5.69.1 Serimmune Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.70 Siemens Healthcare Diagnostics Inc Company Overview 122

5.70.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 122

5.71 T2 Biosystems Inc Company Overview 123

5.71.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 123

5.72 Taizhou ZECEN Biotech Co Ltd Company Overview 125

5.72.1 Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 125

5.73 Techinvention Lifecare Pvt Ltd Company Overview 126

5.73.1 Techinvention Lifecare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

5.74 The Walter and Eliza Hall Institute of Medical Research Company Overview 127

5.74.1 The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 127

5.75 Transfusion & Transplantation Technologies (Inactive) Company Overview 128

5.75.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

5.76 University of California Company Overview 129

5.76.1 University of California Pipeline Products & Ongoing Clinical Trials Overview 129

5.77 University of Colorado Company Overview 130

5.77.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 130

5.78 University of Edinburgh Company Overview 131

5.78.1 University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 131

5.79 University of Georgia Company Overview 132

5.79.1 University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 132

5.80 University of Grenoble Alpes Company Overview 135

5.80.1 University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview 135

5.81 University of Oxford Company Overview 136

5.81.1 University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 136

5.82 University of Tennessee Company Overview 137

5.82.1 University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview 137

5.83 Virginia Commonwealth University Company Overview 138

5.83.1 Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 138

5.84 Washington University in St Louis Company Overview 139

5.84.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 139

5.85 Washington University School of Medicine Company Overview 140

5.85.1 Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 140

6 Parasitology & Mycology- Recent Developments 141

6.1 Dec 05, 2023: Siemens Healthineers Appoints Vivek Kanade as New Head For Its Middle East and Africa Operations 141

6.2 Nov 20, 2023: Gen-Probe Receives Additional 510(K) Clearance For APTIMA Trichomonas Vaginalis Assay 141

6.3 Oct 24, 2023: T2 Biosystems Highlights New Clinical Data Presented at IDWeek 2023 Conference 141

6.4 Aug 29, 2023: Co-Diagnostics Appoints Chief Regulatory Affairs Officer 142

6.5 Jun 05, 2023: T2 Biosystems announces submission for FDA Breakthrough Device Designation for Candida Auris Diagnostic Test 143

6.6 May 05, 2023: Co-Diagnostics announces first quarter 2023 earnings release date and webcast 143

6.7 Apr 20, 2023: QIAGEN announces expansion of supervisory board 144

6.8 Apr 05, 2023: T2 Biosystems announces webinar and white paper highlighting T2Candida Panel Clinical Data and best practices 144

6.9 Mar 09, 2023: Co-diagnostics Announces Fourth Quarter and Full Year 2022 Earnings Release Date and Webcast 145

6.10 Feb 07, 2023: QIAGEN Exceeds Outlook for Fourth Quarter and Full-Year 2022 With 14% CER Sales Growth in FY 2022 From Non-COVID Product Groups 146

7 Appendix 147

7.1 Methodology 147

7.2 About GlobalData 150

7.3 Contact Us 150

7.4 Disclaimer 150

Table

Parasitology & Mycology – Pipeline Products by Stage of Development 16

Parasitology & Mycology – Pipeline Products by Territory 17

Parasitology & Mycology – Pipeline Products by Regulatory Path 18

Parasitology & Mycology – Pipeline Products by Estimated Approval Date 19

Parasitology & Mycology Companies – Pipeline Products by Stage of Development 20

Parasitology & Mycology – Pipeline Products by Stage of Development 24

Abacus Diagnostica Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

GenomEra Candidemia Assay – Product Status 27

GenomEra Candidemia Assay – Product Description 27

Access Bio Inc Pipeline Products & Ongoing Clinical Trials Overview 28

RosGENE For Malaria – Product Status 28

RosGENE For Malaria – Product Description 28

Acobiom Pipeline Products & Ongoing Clinical Trials Overview 29

Diagnostic Test – Leishmania – Product Status 29

Diagnostic Test – Leishmania – Product Description 29

Adaltis Srl Pipeline Products & Ongoing Clinical Trials Overview 30

MOLgen DNA Candida Albicans / Fungi Set 2 Kit – Product Status 30

MOLgen DNA Candida Albicans / Fungi Set 2 Kit – Product Description 31

MOLgen DNA Candida Albicans Set 2 Kit – Product Status 31

MOLgen DNA Candida Albicans Set 2 Kit – Product Description 31

MOLgen DNA Candida Famata / Candida Guilliermondii Set 2 Kit – Product Status 32

MOLgen DNA Candida Famata / Candida Guilliermondii Set 2 Kit – Product Description 32

MOLgen DNA Candida Krusei / Candida Glabrata Set 2 Kit – Product Status 32

MOLgen DNA Candida Krusei / Candida Glabrata Set 2 Kit – Product Description 33

MOLgen DNA Candida Parapsilosis / Candida Tropicalis Set 2 Kit – Product Status 33

MOLgen DNA Candida Parapsilosis / Candida Tropicalis Set 2 Kit – Product Description 33

MOLgen DNA Toxoplasma Gondii Set 2 Kit – Product Status 34

MOLgen DNA Toxoplasma Gondii Set 2 Kit – Product Description 34

MOLgen DNA Trichomonas Vaginalis Set 2 Kit – Product Status 34

MOLgen DNA Trichomonas Vaginalis Set 2 Kit – Product Description 35

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 36

Immunoblot Assay – Cryptococcus – Product Status 36

Immunoblot Assay – Cryptococcus – Product Description 36

Antigen Discovery Inc Pipeline Products & Ongoing Clinical Trials Overview 37

Vaccine Mediated Protection Diagnostic Test – Product Status 37

Vaccine Mediated Protection Diagnostic Test – Product Description 37

Applied BioCode Inc Pipeline Products & Ongoing Clinical Trials Overview 38

Fungal Panel Test – Product Status 38

Fungal Panel Test – Product Description 38

Aptus Biotech SL Pipeline Products & Ongoing Clinical Trials Overview 39

Apta-Leish – Product Status 39

Apta-Leish – Product Description 39

Attogene Corp Pipeline Products & Ongoing Clinical Trials Overview 40

Lateral Flow Diagnostic Test – Malaria – Product Status 40

Lateral Flow Diagnostic Test – Malaria – Product Description 40

Auburn University Pipeline Products & Ongoing Clinical Trials Overview 41

Diagnostic Test – Fusariosis – Product Status 41

Diagnostic Test – Fusariosis – Product Description 41

Axxin Pipeline Products & Ongoing Clinical Trials Overview 42

Blood Test – Malaria – Product Status 42

Blood Test – Malaria – Product Description 42

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 43

Diagnostic Test – Malaria – Product Status 43

Diagnostic Test – Malaria – Product Description 43

DxN VERIS Trichomonas Assay – Product Status 44

DxN VERIS Trichomonas Assay – Product Description 44

BioSynesis Inc Pipeline Products & Ongoing Clinical Trials Overview 45

Rapid Diagnostic Kit – Candida Infections – Product Status 45

Rapid Diagnostic Kit – Candida Infections – Product Description 45

Biotechnology Assets SA Pipeline Products & Ongoing Clinical Trials Overview 46

BNTIVD001 Assay – Chagas Disease – Product Status 46

BNTIVD001 Assay – Chagas Disease – Product Description 46

Biotype Innovation GmbH Pipeline Products & Ongoing Clinical Trials Overview 47

Modaplex System – Fungal Panel Assay – Product Status 47

Modaplex System – Fungal Panel Assay – Product Description 47

Cascade Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 48

RCEA Assay – Malaria – Product Status 48

RCEA Assay – Malaria – Product Description 48

Cepheid Inc Pipeline Products & Ongoing Clinical Trials Overview 49

Mycology Panel Assay – Product Status 49

Mycology Panel Assay – Product Description 49

Cerebro Biosystems Pipeline Products & Ongoing Clinical Trials Overview 50

FunguSeq – Product Status 50

FunguSeq – Product Description 50

Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 51

Chagas Disease Antigen Test – Product Status 51

Chagas Disease Antigen Test – Product Description 51

Ellume Ltd Pipeline Products & Ongoing Clinical Trials Overview 52

ESP-Based Diagnostic Test – Malaria – Product Status 52

ESP-Based Diagnostic Test – Malaria – Product Description 52

EUROIMMUN US LLC Pipeline Products & Ongoing Clinical Trials Overview 53

Diagnostic Kit – Candida Krusei – Product Status 53

Diagnostic Kit – Candida Krusei – Product Description 53

Diagnostic Kit – Candida Tropicalis – Product Status 54

Diagnostic Kit – Candida Tropicalis – Product Description 54

FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview 55

Diagnostic Test – Schistosomiasis – Product Status 55

Diagnostic Test – Schistosomiasis – Product Description 55

Foundation for Innovative New Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 56

High Throughput LAMP Kit – Malaria – Product Status 56

High Throughput LAMP Kit – Malaria – Product Description 56

Single Format IgM Quantification Test – Product Status 57

Single Format IgM Quantification Test – Product Description 57

Fungea AB Pipeline Products & Ongoing Clinical Trials Overview 58

Immunological Assay – Candida – Product Status 58

Immunological Assay – Candida – Product Description 58

G Medical Health and Wellness Pipeline Products & Ongoing Clinical Trials Overview 59

Trichomoniasis Test – Product Status 59

Trichomoniasis Test – Product Description 59

Genetag Technology, Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Dual-iDDS Probe Multiplex Test – Product Status 60

Dual-iDDS Probe Multiplex Test – Product Description 60

Gennova Biopharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 61

Diagnostic Test – Leishmania Donovani – Product Status 61

Diagnostic Test – Leishmania Donovani – Product Description 61

Genome Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 62

Echinococcous Real Time PCR Kit – Product Status 62

Echinococcous Real Time PCR Kit – Product Description 62

Pan Fungal Real Time PCR Kit – Product Status 63

Pan Fungal Real Time PCR Kit – Product Description 63

T. Solium Real Time PCR Kit – Product Status 63

T. Solium Real Time PCR Kit – Product Description 64

Toxoplasma Gondii Real Time PCR Kit – Product Status 64

Toxoplasma Gondii Real Time PCR Kit – Product Description 64

George Mason University Pipeline Products & Ongoing Clinical Trials Overview 65

Chagas Urine Nanoparticle Test – Product Status 65

Chagas Urine Nanoparticle Test – Product Description 65

Great Basin Scientific Inc. Pipeline Products & Ongoing Clinical Trials Overview 66

Candida Blood Infections Panel – Product Status 66

Candida Blood Infections Panel – Product Description 66

Stool Parasite Pathogens Panel – Product Status 67

Stool Parasite Pathogens Panel – Product Description 67

HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 68

ImmunoSignature Test – Chagas – Product Status 68

ImmunoSignature Test – Chagas – Product Description 68

Immunetics Inc Pipeline Products & Ongoing Clinical Trials Overview 69

Diagnostic Test – Chagas Disease – Product Status 69

Diagnostic Test – Chagas Disease – Product Description 69

InBios International Inc Pipeline Products & Ongoing Clinical Trials Overview 70

Strongyloides Detect IgG ELISA – Product Status 70

Strongyloides Detect IgG ELISA – Product Description 70

Institute for Development Research Pipeline Products & Ongoing Clinical Trials Overview 71

Diagnostic Assay – Neonatal Toxoplasmosis – Product Status 71

Diagnostic Assay – Neonatal Toxoplasmosis – Product Description 71

Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 72

299-2 Monoclonal Antibody Assay – Malaria – Product Status 72

299-2 Monoclonal Antibody Assay – Malaria – Product Description 72

2B4 Monoclonal Antibody Assay – Malaria – Product Status 73

2B4 Monoclonal Antibody Assay – Malaria – Product Description 73

Diagnostic Test – Strongyloides Stercoralis – Product Status 73

Diagnostic Test – Strongyloides Stercoralis – Product Description 74

MAG1 Assay – Chronic Toxoplasma Infection – Product Status 74

MAG1 Assay – Chronic Toxoplasma Infection – Product Description 74

PVALD Monoclonal Antibody Assay – Malaria – Product Status 74

PVALD Monoclonal Antibody Assay – Malaria – Product Description 75

L2 Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 76

Diagnostic Assay – Babesia Microti – Product Status 76

Diagnostic Assay – Babesia Microti – Product Description 76

London School of Hygiene & Tropical Medicine Pipeline Products & Ongoing Clinical Trials Overview 77

Diagnostic Test – Monkey Malaria – Product Status 77

Diagnostic Test – Monkey Malaria – Product Description 77

Luminex Corp Pipeline Products & Ongoing Clinical Trials Overview 78

Fungal Panel Assay – Product Status 78

Fungal Panel Assay – Product Description 78

Mahidol Oxford Tropical Medicine Research Unit Pipeline Products & Ongoing Clinical Trials Overview 79

Genetic Test – Malaria – Product Status 79

Genetic Test – Malaria – Product Description 79

Masaryk University Pipeline Products & Ongoing Clinical Trials Overview 80

Diagnostic Test – Invasive Aspergillosis – Product Status 80

Diagnostic Test – Invasive Aspergillosis – Product Description 80

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 81

Diagnostic Test – Malaria – Product Status 81

Diagnostic Test – Malaria – Product Description 81

McGill University Pipeline Products & Ongoing Clinical Trials Overview 82

Biomarker Assay – Babesia – Product Status 82

Biomarker Assay – Babesia – Product Description 82

Biomarker Assay – Chagas – Product Status 83

Biomarker Assay – Chagas – Product Description 83

Meridian Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview 84

Illumigene Giardia Assay – Product Status 84

Illumigene Giardia Assay – Product Description 84

Microbiologics Inc Pipeline Products & Ongoing Clinical Trials Overview 85

E-Sphere Stool DNA Extraction Kit – Cryptosporidium – Product Status 85

E-Sphere Stool DNA Extraction Kit – Cryptosporidium – Product Description 85

E-Sphere Stool DNA Extraction Kit – Giardia – Product Status 86

E-Sphere Stool DNA Extraction Kit – Giardia – Product Description 86

R-Sphere Cypto-Giardia Detect – Product Status 86

R-Sphere Cypto-Giardia Detect – Product Description 87

R-Sphere Microsporidia Detect – Product Status 87

R-Sphere Microsporidia Detect – Product Description 87

MiraVista Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 88

Coccidioides Cytokine Release Assay – Product Status 88

Coccidioides Cytokine Release Assay – Product Description 88

MND Diagnostic LTD Pipeline Products & Ongoing Clinical Trials Overview 89

Diagnostic Kit – Malaria – Product Status 89

Diagnostic Kit – Malaria – Product Description 89

MycoDART Inc Pipeline Products & Ongoing Clinical Trials Overview 90

MycoDART-PCR Candida Diagnostic Panel – Product Status 90

MycoDART-PCR Candida Diagnostic Panel – Product Description 90

Mylab Discovery Solutions Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 91

Compact x System – Malaria Test – Product Status 91

Compact x System – Malaria Test – Product Description 91

Nagasaki University Pipeline Products & Ongoing Clinical Trials Overview 92

Diagnostic Tool – Malaria – Product Status 92

Diagnostic Tool – Malaria – Product Description 92

Nanosphere Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 93

Verigene Blood Culture – Fungal Test (BC-F) – Product Status 93

Verigene Blood Culture – Fungal Test (BC-F) – Product Description 93

Verigene Yeast Blood Culture Test (BC-Y) – Product Status 94

Verigene Yeast Blood Culture Test (BC-Y) – Product Description 94

NextGen Invitro Diagnostics Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 95

Leish LAMP Test – Product Status 95

Leish LAMP Test – Product Description 95

Novacyt SA Pipeline Products & Ongoing Clinical Trials Overview 96

Diagnostic Assay – Aspergillus – Product Status 96

Diagnostic Assay – Aspergillus – Product Description 96

Diagnostic Assay – Pneumocystis – Product Status 97

Diagnostic Assay – Pneumocystis – Product Description 97

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 98

Paper Strip Test – Malaria – Product Status 98

Paper Strip Test – Malaria – Product Description 98

OpGen Inc Pipeline Products & Ongoing Clinical Trials Overview 99

Multi-Drug Resistance Fungi Testing Kit – Product Status 99

Multi-Drug Resistance Fungi Testing Kit – Product Description 99

OPKO Health Inc Pipeline Products & Ongoing Clinical Trials Overview 100

mChip – Malaria – Product Status 100

mChip – Malaria – Product Description 100

Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview 101

Ring-Screening – Taenia Solium Infection – Product Status 101

Ring-Screening – Taenia Solium Infection – Product Description 101

Ortho Clinical Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview 102

VITROS XT 7600 Integrated System – Chagas Assay – Product Status 102

VITROS XT 7600 Integrated System – Chagas Assay – Product Description 102

Pai Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Diagnostic Screening Test – Chagas Disease – Product Status 103

Diagnostic Screening Test – Chagas Disease – Product Description 103

Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 104

PKL PPC – Torch – ANTI TOXO IGG – Product Status 104

PKL PPC – Torch – ANTI TOXO IGG – Product Description 104

PKL PPC – Torch – ANTI TOXO IGM – Product Status 105

PKL PPC – Torch – ANTI TOXO IGM – Product Description 105

Peruvian Cayetano Heredia University Pipeline Products & Ongoing Clinical Trials Overview 106

Serodiagnostic Assay – Neurocysticercosis – Product Status 106

Serodiagnostic Assay – Neurocysticercosis – Product Description 106

Phagolum Ltd. Pipeline Products & Ongoing Clinical Trials Overview 107

Diagnostic Test – Fungal Infections – Product Status 107

Diagnostic Test – Fungal Infections – Product Description 107

PixCell Medical Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 108

Diagnostic Test – Malaria – Product Status 108

Diagnostic Test – Malaria – Product Description 108

Praxis Pharmaceutical SAU Pipeline Products & Ongoing Clinical Trials Overview 109

Diagnostic Kit – Chagas Disease – Product Status 109

Diagnostic Kit – Chagas Disease – Product Description 109

Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview 110

Biomarker Diagnostic Test – Malaria – Product Status 110

Biomarker Diagnostic Test – Malaria – Product Description 110

Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 111

QIAensemble 400 – Candida Species – Product Status 111

QIAensemble 400 – Candida Species – Product Description 111

QIAensemble 400 – Trichomonas Vaginalis – Product Status 112

QIAensemble 400 – Trichomonas Vaginalis – Product Description 112

QIAsymphony – Malaria – Product Status 112

QIAsymphony – Malaria – Product Description 112

QuantiFERON – Leishmania Test – Product Status 113

QuantiFERON – Leishmania Test – Product Description 113

RealSeq Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 114

RiboMarker Valley Fever LDT – Product Status 114

RiboMarker Valley Fever LDT – Product Description 114

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

Cobas 5800 System – Babesia Assay – Product Status 115

Cobas 5800 System – Babesia Assay – Product Description 115

Cobas 5800 System – Malaria – Product Status 116

Cobas 5800 System – Malaria – Product Description 116

Cobas 6000 Analyzer Series With c 501 Module – Toxo IgM Assay – Product Status 116

Cobas 6000 Analyzer Series With c 501 Module – Toxo IgM Assay – Product Description 116

Cobas 8000 Analyzer Series With c 702 Module – Toxo IgM Assay – Product Status 117

Cobas 8000 Analyzer Series With c 702 Module – Toxo IgM Assay – Product Description 117

Cobas Malaria Assay – Product Status 117

Cobas Malaria Assay – Product Description 118

Integrated Modular Analytics – Toxo IgM Test – Product Status 118

Integrated Modular Analytics – Toxo IgM Test – Product Description 118

Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 119

Allplex – Malaria Assay – Product Status 119

Allplex – Malaria Assay – Product Description 119

Serimmune Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Blood Based Diagnostic Test – Chagas Disease – Product Status 120

Blood Based Diagnostic Test – Chagas Disease – Product Description 120

Multiplex Assay – Cysticercosis – Product Status 121

Multiplex Assay – Cysticercosis – Product Description 121

Multiplex Assay – Toxoplasmosis – Product Status 121

Multiplex Assay – Toxoplasmosis – Product Description 121

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 122

ADVIA Centaur CP Immunoassay System – Toxoplasma IgM Assay – Product Status 122

ADVIA Centaur CP Immunoassay System – Toxoplasma IgM Assay – Product Description 122

T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview 123

T2Candida Panel – Product Status 123

T2Candida Panel – Product Description 123

T2Cauris Panel – Product Status 124

T2Cauris Panel – Product Description 124

Taizhou ZECEN Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 125

TOXO IgG Detection Kit – Product Status 125

TOXO IgG Detection Kit – Product Description 125

Techinvention Lifecare Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 126

Molecular Diagnostic Kit – Malaria – Product Status 126

Molecular Diagnostic Kit – Malaria – Product Description 126

The Walter and Eliza Hall Institute of Medical Research Pipeline Products & Ongoing Clinical Trials Overview 127

Blood Test – Malaria – Product Status 127

Blood Test – Malaria – Product Description 127

Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 128

Aegis – Chagas Disease – Product Status 128

Aegis – Chagas Disease – Product Description 128

University of California Pipeline Products & Ongoing Clinical Trials Overview 129

Biomarker Test – Coccidioidomycosis – Product Status 129

Biomarker Test – Coccidioidomycosis – Product Description 129

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 130

Diagnostic Test – Babesia – Product Status 130

Diagnostic Test – Babesia – Product Description 130

University of Edinburgh Pipeline Products & Ongoing Clinical Trials Overview 131

Malaria Diagnostic Test – Product Status 131

Malaria Diagnostic Test – Product Description 131

University of Georgia Pipeline Products & Ongoing Clinical Trials Overview 132

Diagnostic Assay – Chagas Disease – Product Status 132

Diagnostic Assay – Chagas Disease – Product Description 132

ELISA-mAbCAA – Product Status 133

ELISA-mAbCAA – Product Description 133

IMS-mAbCCA – Product Status 133

IMS-mAbCCA – Product Description 134

University of Grenoble Alpes Pipeline Products & Ongoing Clinical Trials Overview 135

SensiFONG Assay – Product Status 135

SensiFONG Assay – Product Description 135

University of Oxford Pipeline Products & Ongoing Clinical Trials Overview 136

Diagnostic Test – Malaria – Product Status 136

Diagnostic Test – Malaria – Product Description 136

University of Tennessee Pipeline Products & Ongoing Clinical Trials Overview 137

Diagnostic Assay – Toxoplasma Infection – Product Status 137

Diagnostic Assay – Toxoplasma Infection – Product Description 137

Virginia Commonwealth University Pipeline Products & Ongoing Clinical Trials Overview 138

Diagnostic Test – Tick Disease – Product Status 138

Diagnostic Test – Tick Disease – Product Description 138

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 139

Diagnostic Assay – Filarial Infections – Product Status 139

Diagnostic Assay – Filarial Infections – Product Description 139

Washington University School of Medicine Pipeline Products & Ongoing Clinical Trials Overview 140

Diagnostic Test – River Blindness – Product Status 140

Diagnostic Test – River Blindness – Product Description 140

Glossary 149

Figures

Parasitology & Mycology – Pipeline Products by Stage of Development 15_x000D_

Parasitology & Mycology – Pipeline Products by Territory 16_x000D_

Parasitology & Mycology – Pipeline Products by Regulatory Path 17_x000D_

Parasitology & Mycology – Pipeline Products by Estimated Approval Date 18_x000D_

Frequently asked questions

Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies thematic reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies in real time.

  • Access a live Parasitology and Mycology Rapid Tests and POC Pipeline by Development Stages, Segments, Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.